Navigation Links
Cleft lip and palate are due to abnormality in brain structure

Clefts of the lip and palate are associated with permutation in brain structure that appear to cause cognitive dysfunction, according to a study recently conducted by researchers at the University of Iowa.//

Studying 54 adult men with nonsyndromic facial clefts and 54 male control subjects, the researchers used magnetic resonance imaging to study brain volume and tissue composition. They found that the volume of the anterior portion of the cerebrum was enlarged in men with clefting and that this enlargement is inversely associated with Full Scale IQ, which measures verbal and non-verbal skills. Those with clefting also showed decreased volume in the posterior cerebrum and cerebellum as well as decreased cerebrospinal fluid.//

The left temporal lobe was most affected in the subjects with clefting, the Iowa team noted, where language is predominantly represented and processed, especially in men. The subjects exhibited mildly decreased IQ compared with the control subjects and specific language function difficulties.


'"/>




Page: 1

Related medicine news :

1. Cleft Lip And Cleft Palate Can Now Be Predicted Before Birth
2. Learning the Value of Prevention and Treatment in Oral Clefting
3. Being Teased Predicts Poor Psychological Functioning in Youth With Cleft Lip
4. Babies with Cleft Conditions, Pierre Robin Sequence May Need Extended Treatment for Poor Feeding Skills
5. Oral Hygiene Can Prevent Tooth Decay for Patients With Cleft Conditions
6. Folic Acid Reduces Risk Of Cleft Lip
7. Cleft Palate in Fetal Mice Prevented by Treating
8. Certain Drug Treatment Associated With Orofacial Clefts
9. Smoking during pregnancy increases risk of cleft palate
10. Dyslexia due to cerebellum abnormality
11. Inflammatory bowel disease linked to genetic abnormality
Post Your Comments:
Other Medicine News:Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 2Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 3Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 4Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 5Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 6Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 7Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 8Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 9Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 10Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 11Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 12Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 13Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 14Health News:Practice Greenhealth Hires First Exec 2Health News:Gerresheimer Starts the Year Successfully in 2008 2Health News:Gerresheimer Starts the Year Successfully in 2008 3Health News:Gerresheimer Starts the Year Successfully in 2008 4Health News:Northwest Songwriter Dean Backholm Featured on National March of Dimes CD 2Health News:Kent State University Stark Campus to Confer First Class of Nursing Students 2Health News:Clergy Abuse Victims Want UN to Investigate Vatican 2
Breaking Medicine Technology:Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 1Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 2Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 3Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 4Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 5Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 6President Obama Misleads on Abortion Funding in Health Care Reform 54931 1President Obama Misleads on Abortion Funding in Health Care Reform 54931 2Kaiser Workers Launch Statewide Pickets 54929 1